Quality Biological Inc.

Quality Biological Inc., a woman-owned, minority-owned small disadvantaged business headquartered in Gaithersburg, Maryland, manufactures and supplies laboratory chemicals, reagents, media, cell culture consumables, and biological materials to federal research agencies as a prime contractor across multiple vehicle types, competing predominantly in full-and-open procurement rather than set-aside awards.

The company operates across 25 distinct customer agencies with extreme concentration in NIH and Defense Logistics Agency procurement. The Defense Logistics Agency Troop Support Medical dominates the award count at 1,318 awards (combined potential value $4.2 million), but this high-volume, low-dollar-value distribution reverses when ranked by potential-value concentration: the National Institute of Allergy and Infectious Diseases anchors the portfolio at $63.6 million combined potential value across 17 awards, with a related NIAID sub-office adding another $55.3 million across 13 awards. The NIH Office of Logistics and Acquisition Operations carries 188 awards valued at $12.1 million combined potential. Together, these three customer entities represent roughly 13% of the combined potential value across all awards, reflecting Quality Biological's role as a critical supplier of laboratory materials to NIH's research mission and a high-volume commodity supplier to DLA medical logistics.

Quality Biological holds a dominant position on multiple federal vehicles anchoring its federal work. The company operates under an Indefinite Delivery Contract (SPE2DE14D0004) with the Defense Logistics Agency carrying 1,063 task orders (combined potential value $453 thousand); a Blanket Purchase Agreement (HHSN263200000052006B) with NIH generating 376 task orders ($3.1 million combined potential value); a second IDC (SPE2DE20D0001) with DLA carrying 187 task orders ($80 thousand); a BPA (HHSN263201600031B) producing 170 task orders ($1.5 million); and a GSA Federal Supply Schedule (V797P5471X) under which 121 task orders total $377 thousand. A recent single-award BPA with the NIH Office of Logistics and Acquisition Operations, awarded November 29, 2023, carries a $10 million ceiling and runs through November 30, 2026. Recent prime work includes a $25.4 million cost-plus-fixed-fee definitive contract (Total Small Business set-aside) with the National Institute of Allergy and Infectious Diseases for production, procurement, storage, and maintenance of reagents and assays supporting preclinical and clinical AIDS vaccine research through April 7, 2032; multiple delivery orders under the NIH BPA for phosphate-buffered saline ($129,500), high-purity water ($129,500), tissue culture dishes ($92,318.80), and serological pipettes ($54,700) issued between January and May 2026; and smaller purchase orders for sterilized sheath fluid and Dulbecco's phosphate-buffered saline supporting cell sorter and cell culture operations at the NIAID Vaccine Research Center.

The award footprint shows steady activity concentrated in laboratory supplies and pharmaceutical/medical device manufacturing. The top five NAICS categories are Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (1,114 awards), Pharmaceutical Preparation Manufacturing (498 awards), All Other Miscellaneous Manufacturing (188 awards), Other Scientific and Technical Consulting Services (188 awards), and Analytical Laboratory Instrument Manufacturing (138 awards). The top PSC codes track this distribution: Laboratory Equipment and Supplies (1,467 awards), Drugs and Biologicals (521 awards), Chemicals (122 awards), Support Professional-Other (80 awards), and Ophthalmic Instruments (40 awards).

Recent activity shows light but sustained federal engagement. The source captures four awards in 2026 (two months into the fiscal year), two in 2025, two in 2024, 30 in 2023, and eight in 2022. The recompete cliff is minimal: only three awards (combined potential value $316 thousand) carry ultimate completion dates within the next twenty-four months, indicating a favorable contract-extension and renewal posture.

SCI-reported service-contract invoicing totaled $7.1 million across three prime records spanning fiscal years 2023–2024, with FY2023 showing $3.4 million across 3.6 FTEs and FY2024 showing $3.6 million across 3.7 FTEs. Government-paid median hourly rates on SCI-reportable prime contracts ran around $466 per hour (10th percentile $462/hr, 90th percentile $471/hr), indicating professional-grade technical delivery. The company carries zero sub-engagement across SCI prime contracts, performing all work directly. The SCI dataset reflects only service contracts above the $150,000 reporting threshold and excludes goods, product sales, and non-federal work; Quality Biological's federal revenue footprint is substantially larger, dominated by goods-based delivery orders and BPA calls under the vehicle structure outlined above. All work is performed at the contractor's Montgomery Village, Maryland facility.

Quality Biological Inc. provides specialized services for federal government agencies and biotechnology organizations, ranging from reagent support for vaccine development to customized solutions for cell and molecular biology applications. Quality is our number one priority. Our Contract Services Division is a motivated team of experienced scientists and dedicated technicians who understand customers' needs for quality products and services. We are flexible, work collaboratively with our customers, and operate carefully with controlled Standard Operating Procedures.